Funder
National Key Research and Development Program of China
Publisher
Springer Science and Business Media LLC
Reference7 articles.
1. Aydh A, Sari Motlagh R, Alamri A et al (2023) Comparison between different neoadjuvant chemotherapy regimens and local therapy alone for bladder cancer: a systematic review and network meta-analysis of oncologic outcomes. World J Urol. https://doi.org/10.1007/s00345-023-04478-w
2. Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors) (2022) Cochrane handbook for systematic reviews of interventions version 6.3 (updated February 2022). Cochrane. www.training.cochrane.org/handbook
3. Yuan Y, Liu L, Chen H et al (2016) Comprehensive characterization of molecular differences in cancer between male and female patients. Cancer Cell 29:711–722. https://doi.org/10.1016/j.ccell.2016.04.001
4. Song Y, Qin C, Zhang C et al (2023) GNRH family genes contributed to gender-specific disparity of bladder cancer prognosis through exerting opposite regulatory roles between males and females. J Cancer Res Clin Oncol. https://doi.org/10.1007/s00432-023-04640-2
5. Yanagisawa T, Kawada T, Quhal F et al (2023) Impact of sex on the efficacy of immune checkpoint inhibitors in kidney and urothelial cancers: a systematic review and meta-analysis. World J Urol 41:1763–1774. https://doi.org/10.1007/s00345-023-04412-0